Daniel Allar

""



Daniel joined TriMed’s Chicago editorial team in 2017 as a Cardiovascular Business writer. He previously worked as a writer for daily newspapers in North Dakota and Indiana.

LATEST ARTICLES BY THIS AUTHOR

Relationships Revealed: Companies Paid U.S. Cardiologists $520M in Sunshine Act’s First 3 Years
A Step Closer to Precision Medicine? Gene Editing Process Leads to Personalized Advice for Heart Patient
Heart failure readmissions not targeted by HRRP also declined after policy announcement
Post-PCI changes in FFR predict outcomes, symptomatic improvement
‘Patient No. 1’ from a Hep C heart transplant study shares his story
Delayed discharge after TAVR growing less common, tied to worse outcomes
Bleeding monitoring system for endovascular procedures gains FDA approval
AHA: FDA must continue Gottlieb's fight against e-cig industry
AHA releases new statement on best practices for BP measurement
Critics concerned FDA is playing cheerleader during Apple’s health push